Gå ubegrenset med Magzter GOLD

Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$149.99
 
$74.99/År

Prøve GULL - Gratis

Health

Chronicle Pharmabiz

Role of global pharma industry...

By addressing the challenges of sample collection, storage, and transport, the device can improve the accuracy and timeliness of TB diagnosis, which is critical for effective disease management.

1 min  |

August 21, 2025

Chronicle Pharmabiz

Guj FDCA gets ₹32 cr to expand Surat drug testing lab

THE Gujarat Food and Drug Control Administration (FDCA) has received Rs. 32 crore to expand its drug testing laboratory in Surat, as part of a larger state initiative to strengthen pharmaceutical quality control infrastructure.

1 min  |

August 21, 2025

Chronicle Pharmabiz

Pfizer launches PCV20 for adults in India

PFIZER has announced the PFIZER has an unext-genpneumoeration 20-valent coccal conjugate vaccine (PCV20) for adults in India.

1 min  |

August 21, 2025

Chronicle Pharmabiz

Quality Should Rein Supreme

At its 15th general body meeting recently, the Chennai-based Consortium of Indian Pharmaceutical Marketers and Manufacturers Associations (CIPMMA) passed a resolution urging the Union Health Ministry to exempt pharmaceutical marketers from the responsibility of drug product quality and other regulatory compliances.

2 min  |

August 21, 2025

Chronicle Pharmabiz

Centre unveils State Health Regulatory Excellence Index

UNION health ministry has launched the State Health Regulatory Excellence Index (SHRESTH), a first-of-its-kind national initiative to benchmark and strengthen state drug regulatory systems through a transparent, data-driven framework.

1 min  |

August 21, 2025

Chronicle Pharmabiz

MDC's decision to reject Dr Reddy's plea on Omaze ODT accepted

THE National Pharmaceutical Pricing Authority (NPPA) has accepted the recommendation of its Multidisciplinary Committee (MDC) of Experts to reject an application of Dr Reddy's Laboratories seeking special price for omeprazole delayed release orally disintegrating tablet of a certain dosage strength.

2 min  |

August 21, 2025

Chronicle Pharmabiz

Siddha graduates irked over Siddha's exclusion from UAE's recognized Indian medicines

THE Siddha graduates and postgraduates (BSMS and MD Siddha) in Tamil Nadu, as well as those currently working in the UAE, are protesting against the exclusion of the Siddha system from the list of recognized Indian traditional treatment systems in the UAE.

2 min  |

August 21, 2025

Chronicle Pharmabiz

EMA grants orphan designation to Sanofi's rilzabrutinib

SANOFI announced that the European Medicines Agency (EMA) has granted orphan designation to rilzabrutinib, a reversible covalent Bruton's tyrosine kinase (BTK) inhibitor, for IgG4-related disease (IgG4-RD).

1 min  |

August 21, 2025

Chronicle Pharmabiz

Laborate Pharma secures EU-GMP certification

LABORATE Pharmaceuticals, one of India's prominent pharmaceutical manufacturing and exporting companies, has announced that its manufacturing site in Laborate Pharmaceuticals India Ltd, 111, Paonta Sahib, Himachal Pradesh (HP) has been granted the EU-GMP (European Union - Good Manufacturing Practice) certification from the relevant European regulatory agency.

1 min  |

August 21, 2025

Chronicle Pharmabiz

Role of global pharma industry in TB diagnostics - II

IN the first part of this article, the authors described the TB remains a persistent global health challenge, particularly in lowand middle-income countries, and the global pharma industry has been at the forefront of TB diagnostics. In this concluding part, they are discussing about traditional sample transportation methods, DBS and dried sputum technologies, advanced molecular transport media & impact on TB diagnostics and public health.

5 min  |

August 21, 2025

Chronicle Pharmabiz

Indian hospitals support US FDA norms on antibacterial therapies

INDIAN hospitals strongly support US FDA norms on antibacterial therapies, offering new hope to patients battling serious bacterial infections.

1 min  |

August 21, 2025

Chronicle Pharmabiz

Pharmacy admissions in limbo as PCI approvals delay counselling

THE pharmacy colleges across the country are grappling with a significant challenge, delayed admissions caused by a multitude of state government counselling processes, according to the Association of Pharmacy Teachers of India (APTI).

1 min  |

August 21, 2025

Chronicle Pharmabiz

Centrient with UNGC to reinforce its commitment to sustainable growth

CENTRIENT Pharmaceuticals, a global leader in sustainable B2B manufacturing of antibiotics, statins, and antifungals, has officially joined the United Nations Global Compact (UNGC), the world’s largest corporate sustainability initiative.

1 min  |

August 21, 2025

Chronicle Pharmabiz

Healthcare leads the charge to bridge awareness gap

INDIAN healthcare is coping with a mismatch between medical advances and public awareness.

1 min  |

August 21, 2025

Chronicle Pharmabiz

Sales of JAKS grow 37.4 per cent in FY25

THE Jan Aushadhi Kendras (JAKs), the low cost generic medicine stores under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) scheme of the Department of Pharmaceuticals (DoP), has registered a 37.44 per cent growth in the fiscal year 2024-25, as compared to the previous fiscal year.

1 min  |

August 21, 2025

Chronicle Pharmabiz

Indian healthcare eyes LLMs to tackle fragmented data, ease clinical burden

INDIAN healthcare sees the need to reduce the clinical burden of fragmented data to streamline workflows.

2 min  |

August 21, 2025

Chronicle Pharmabiz

CMHA notifies categories of mental health establishments

THE Central Mental Health Authority (CMHA) has amended the mental healthcare regulations to introduce classifications and categories of mental health establishments in the country, directing the institutions under the categories to register with the Authority.

2 min  |

August 21, 2025

Chronicle Pharmabiz

CDSCO issues draft standards for IVD devices evaluation protocol

THE Central Drugs Standard Control Organisation (CDSCO) has released the draft standards for In-Vitro Diagnostics (IVD) medical devices evaluation protocol, drafted by the Indian Council of Medical Research (ICMR) and the drugs regulator, inviting comments from the stakeholders.

1 min  |

August 21, 2025

Chronicle Pharmabiz

'IPC 74th edition to chalk out next-gen pharma strategy in industry'

THE 74th Indian Pharmaceutical Congress (IPC) is poised to play a transformative role in shaping the future of pharmaceutical education and industry in India.

2 min  |

August 21, 2025

Chronicle Pharmabiz

Enforcement activities crippled in Maharashtra

THE Food and Drug Administration (FDA) Maharashtra, the cornerstone of drug and cosmetic safety for the state's vast 14 crore population, is on the verge of a full-blown crisis.

2 min  |

July 24, 2025
Chronicle Pharmabiz

Chronicle Pharmabiz

LUB raises concerns & demands related to pharma industry

LAGHU Udyog Bharati (LUB), the association representing micro and small industries in the country, has said that it is pursuing various matters related to the micro, small and medium enterprises (MSME) in pharma sector with the Union health ministry and the ministry of chemicals and fertilisers.

2 min  |

July 24, 2025

Chronicle Pharmabiz

CMRI Kolkata launches free cervical cancer vaccination clinic

CK Birla Hospitals - CMRI Kolkata, in a positive step for cancer prevention, launched a free cervical cancer vaccination clinic for girls and young women aged 9 to 26. The clinic will operate on a weekly basis, every Wednesday and Thursday from 1 pm to 4 pm.

2 min  |

July 24, 2025

Chronicle Pharmabiz

'Indian pharma's strength lies in its vigilant regulatory backbone'

NDIA is recognized for its high-quality medicines, due in large part to the vigilant oversight of its regulatory workforce.

2 min  |

July 24, 2025

Chronicle Pharmabiz

MedTech zone programme selected for BRICS+ Global Initiative

In a landmark recognition of India’s growing global footprint in healthcare innovation, the World Health Innovation Forum (WHIF), headquartered at Andhra Pradesh MedTech Zone (AMTZ), has been selected as the only global initiative to join the prestigious BRICS+ Manufacturing Working Group.

1 min  |

July 24, 2025
Chronicle Pharmabiz

Chronicle Pharmabiz

KPRDO acknowledges Emcure's response on stockist appointment

THE Karnataka Pharma Retailers & Distributors Organisation (KPRDO) has acknowledged Emcure Pharma's positive response on the exclusive stockist appointment for special category sales.

1 min  |

July 24, 2025

Chronicle Pharmabiz

CDSCO declares 185 drug samples as NSQ in June

THE Central Drugs Standard Control Organisation (CDSCO) has declared 185 drug samples tested by the Central and State drugs regulatory authorities in the month of June as Not of Standard Quality (NSQ).

1 min  |

July 24, 2025

Chronicle Pharmabiz

PCI asks State Councils to submit data of pharmacists for HPR

HPR is a comprehensive repository of registered and verified practitioners delivering modern as well as traditional medical healthcare services across India. The registry is being created under the Ayushman Bharat Digital Mission (ABDM)

1 min  |

July 24, 2025
Chronicle Pharmabiz

Chronicle Pharmabiz

Telangana DCA issues show cause notices to 149 medical shops

THE Drug Control Administration (DCA) in Telangana has intensified its efforts to combat the illicit sale of abortion kits (abortifacient drugs) across the state.

1 min  |

July 24, 2025

Chronicle Pharmabiz

FPME concerned over DCGI directive not allowing exports meant for sale in India

THE Federation of Pharmaceutical Merchant Exporters (FPME) has expressed concern over an office memorandum (OM) dated January 19, 2024 which directs all port officers and zonal/sub-zonal officers in the Central Drugs Standard Control Organisation (CDSCO), not to allow export of pharmaceutical products labeled as 'meant for sale in India'.

2 min  |

July 24, 2025

Chronicle Pharmabiz

'Improving AMS via novel anti-infectives is the need of the hour'

IMPROVING antimicrobial stewardship (AMS) is crucial in combating antimicrobial resistance (AMR), and the development of novel anti-infectives plays a vital role in this effort. In India, surveillance reports indicate a steady rise in resistance to both first-line and second-line antibiotics over the past six years, a dangerous trend that threatens to overwhelm our healthcare system, informed Dr. Surendran R, consultant – infectious disease and hospital infection control, The SRM Institutes of Medical Science (SIMS), Chennai.

1 min  |

July 24, 2025